The effect of universal influenza immunization on antibiotic prescriptions: An ecological study

Clinical Infectious Diseases

Volumn 49, Issue 5, 2009, Pages 750-756

  Kwong, Jeffrey C ^a,b   Maaten, Sarah ^a   Upshur, Ross E G ^a,b,c   Patrick, David M ^d   Marra, Fawziah ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; INFLUENZA VACCINE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ARTICLE; CANADA; DISEASE ACTIVITY; DRUG EFFECT; DRUG SENSITIVITY; DRUG UPTAKE; IMMUNIZATION; INFLUENZA; PRESCRIPTION; PRIORITY JOURNAL;

EID: 70149087777     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605087     Document Type: Article

References (20)

1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771
2. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1924
3. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341:233-239
4. Ciesla G, Leader S, Stoddard J. Antibiotic prescribing rates in the US ambulatory care setting for patients diagnosed with influenza, 1997-2001. Respir Med 2004; 98:1093-1101
5. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278:901-904 (Pubitemid 27492241)
6. Carrat F, Schwarzinger M, Housset B, Valleron AJ. Antibiotic treatment for influenza does not affect resolution of illness, secondary visits or lost workdays. Eur J Epidemiol 2004; 19:703-705 (Pubitemid 41175139)
7. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-231
8. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-144
9. Tambay JL, Catlin G. Sample design of the national population health survey. Health Rep 1995; 7:29-42.
10. Beland Y. Canadian community health survey-methodological overview. Health Rep 2002; 13:9-14.
11. Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. Use of ezetimibe in the United States and Canada. N Engl J Med 2008; 358:1819-1828 (Pubitemid 351581194)
12. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944-1950 (Pubitemid 28055910)
13. Kwong JC, Stukel TA, Lim J, et al. The effect of universal influenza immunization on mortality and health care use. PLoS Med 2008; 5:e211.
14. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677-1682 (Pubitemid 30740391)
15. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991; 145:445-448
16. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995; 149:1113-1117
17. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998; 338:1405-1412 (Pubitemid 28221981)
18. Monto AS, Webster A, Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother 1999;44(Suppl B):23-29 (Pubitemid 29531321)
19. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163:1667-1672 (Pubitemid 36898954)
20. Morgan S. Sources of variation in provincial drug spending. CMAJ 2004; 170:329-330 (Pubitemid 38223447)